Patent Yard Sign in
Canadian application, no grantCanada

Agents for diagnosis, treatment and cure of amyotrophic lateral sclerosis in humans

CA 2104237 A1 · Owner: Preddie, Rick E. · Inventors: Bergmann, Johanna E.; Preddie, Rick E.

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

Agents for diagnosis and therapy of Amyotrophic Lateral Sclerosis (ALS) disclosed, such agents include anti-sense molecules of one gene implicated in ALS and anti-sense molecules related to two other genes closely related to the gene implicated in ALS.

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed August 3, 1993. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended August 3, 2013.
  • A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by August 3, 2015.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledAugust 3, 1993
GrantedNo grant recorded
Term endedAugust 3, 2013
Patent numberCA 2104237 A1
Classification (IPC)C12N15/57 +2 more

Timeline

Timeline From CIPO dates

1994199619982000200220042006200820102012Application filedAug 3, 1993Term endedAug 3, 2013

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.